Because Expertise Matters
Join Cyberounds®, an online education community for health professionals Sign Up

Log In

Sex-Related Differences in Addiction

Substance use disorder (SUD) is a chronic disease characterized by persistent relapse, despite an individual’s willingness or desire to stay abstinent. Historically, men drink larger amounts of alcohol than women,...
CME credit is no longer available for this conference.

Course Authors

Jill B. Becker, Ph.D. and Jillian E. Hardee, Ph.D.

Dr. Becker is Patricia Y. Gurin Collegiate Professor of Psychology and Research Professor Michigan Neuroscience Institute; Dr. Hardee is Research Assistant Professor in the Department of Psychiatry and Researcher Michigan Neuroscience Institute, University of Michigan, Ann Arbor, MI.

Within the past 12 months, Ds. Becker and Hardee report no commercial conflict of interest.

Albert Einstein College of Medicine, Montefiore Medical Center, CCPD staff and interMDnet staff have nothing to disclose relevant to this activity.

Estimated course time: 1 hour(s).

Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Learning Objectives

Upon completion of this Cyberounds®, you should be able to:

  • Discuss the differences between males and females in the progression of substance use disorder (SUD) from substance use to abuse;

  • Describe the role of ovarian hormones in SUD in females and males;

  • Identify the areas of the brain that play a role in SUD.



The opinions expressed herein are those of the author(s) and do not necessarily represent the views of Einstein-Montefiore or InterMDnet. Please review complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.


Please click below to accept the terms of this CME activity

Courses You Might Like

Caring for Women and Their Families: The Essential Role of Reproductive Rights

Editor's Note: Dr. Stotland is the author/editor of several books on reproductive healthcare: Abortion: Facts and Feelings; Social Change and Women's Reproductive Health; Psychological Aspects of Women’s Health Care: The Interface Between Psychiatry and Obstetrics and Gynecology and Psychiatric Aspects of Reproductive Technology. From 2008-2008, she was the president of the American Psychiatric Association. We invite your comments on this Cyberounds® and will publish a representative sample. Generally, rights in medical care are actions which care
Authors: Nada L. Stotland, M.D., M.P.H.
Estimated Time: 1 Hour

Current and Emerging Therapies for Vulvo-vaginal Atrophy

This presentation may include discussion of commercial products and services. Vulvo-vaginal atrophy (VVA) in peri- and post-menopausal women is caused by declining, then deficient estrogen levels. It frequently results in distressing symptoms that include burning, irritation, discharge and dyspareunia. A Cochrane review (2006) estimates that in healthy women over age 60, 50% experience one or more of these symptoms. Other studies report a similar estimated prevalence of 39-47%, with up to 52% of those affected reporting these
Authors: Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
Estimated Time: 1 Hour

Current Management of Endometriosis

This Cyberounds® will discuss unlabeled use of low-dose estrogen, norethindrone and aromatase inhibitors. Endometriosis remains one of the most complex pathologies faced by OBGYNs and primary care physicians. The overall prevalence of endometriosis in reproductive age women has been estimated to be between 3-10%, but can vary depending on the population studied. Endometriosis affects 12-32% of reproductive age women with pelvic pain and 9-50% of women who are infertile. It is
Authors: Kenan Omurtag, M.D., and Amber R. Cooper, M.D., M.S.C.I.
Estimated Time: 1 Hour

Endometrial Cancer

Type I Tumors Endometrial hyperplasia is thought to be the precursor lesion of these well- to moderately-differentiated endometrioid adenocarcinomas. In a classic study, Kurman et al. followed 170 patients with endometrial hyperplasia who did not undergo a hysterectomy for at least one year. The authors quantified the risk of progression to carcinoma in patients with various pre-cancerous changes. Cancer precursor lesions were classified as either lacking (hyperplasia) or displaying cytologic atypia (atypical hyperplasia). Hyperplasia and atypical hyperplasia were further
Authors: Yevgeniya Ioffe, M.D., and Israel Zighelboim, M.D.
Estimated Time: 1 Hour

Evaluation and Treatment of Polycystic Ovary Syndrome

A 32-year-old obese woman complains of recurrent yeast infections. She was diagnosed with polycystic ovary syndrome (PCOS) at the age of 16 years, based on irregular menstrual periods, recalcitrant acne and hirsutism. She has been using the combination of spironolactone and a birth control pill (ethinyl estradiol/drospirenone) for the past five years, during which time her menses have become regular and her acne and hirsutism have improved. For the last year, she has had fatigue and malaise, so she has
Authors: Daniel A. Dumesic, M.D., Mark O. Goodarzi, M.D., Ph.D., Gregory D. Chazenbalk, Ph.D., David Geller, M.D., and David H. Abbott, Ph.D.
Estimated Time: 1 Hour

Central Nervous System-selective Estrogens: A Safe Estrogen Therapy

Following the publication of the book “Feminine Forever” by Robert Wilson in 1966, the use of hormone replacement therapy (HRT or HT) became popular. In the 1980s, numerous observational studies added further support to the concept that HRT would prevent not only hot flashes and osteoporosis but also heart disease, urinary incontinence and dementia, and would thus improve the quality of life. However, in 1998, the Heart and Estrogen/Progestin Replacement Study (HERS) concluded that the combination of estrogen and progestin
Authors: Istvan Merchenthaler, M.D., Ph.D., D.Sc. and Laszlo Prokai, Ph.D., D.Sc.
Estimated Time: 1 Hour